Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
ID: 357135Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357135

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-255.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (PAR-25-255). This initiative aims to support interdisciplinary research that enhances the understanding of how genetic and non-genetic factors contribute to complex human traits, encouraging applicants to develop innovative theories and models while utilizing large-scale publicly accessible datasets. The funding opportunity is not open to clinical trials and allows for applications of up to five years, with a focus on rigorous scientific design and inclusivity through a Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the open submission date begins on January 5, 2025, with various deadlines extending through 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-255-Full-Announcement.html
    PAR-25-255.html
    The Department of Health and Human Services, through its National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO) titled “Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits” (PAR-25-255). This initiative aims to support interdisciplinary research that enhances understanding of how genetic and non-genetic factors affect complex traits in humans. Applicants are encouraged to develop innovative theories, models, and methods that integrate diverse scientific approaches and utilize large-scale publicly accessible data. Key requirements include forming interdisciplinary teams and submitting a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity and diverse viewpoints in research. The funding opportunity, which is not open to clinical trials, has significant budgetary flexibility and allows applications for up to five years. Key dates include an open submission date of January 5, 2025, and deadlines for various submissions occurring throughout 2025 and 2026. The NIH emphasizes rigorous scientific design, reproducibility of results, and the consideration of social implications in the proposed research approaches, ultimately aiming to advance genomic medicine and health outcomes.
    Similar Opportunities
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Developing novel theory and methods for understanding the genetic architecture of complex human traits" under the R01 Clinical Trial Not Allowed grant program. This initiative aims to support interdisciplinary research that enhances the understanding of how genetic and non-genetic factors contribute to complex trait variation among individuals and populations, encouraging innovative theoretical approaches and the use of large-scale datasets. The program is significant for advancing genetic research, addressing health disparities, and promoting collaborative research environments. Interested applicants, including higher education institutions and non-profits, must submit their applications by February 5, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-302.html.
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity aimed at developing novel theories and methods for understanding the genetic architecture of complex human traits through the R21 Exploratory/Developmental Research Grant mechanism. This initiative seeks interdisciplinary applications that address the interplay of genetic and non-genetic factors influencing trait variation, emphasizing the use of large-scale datasets and innovative approaches from various scientific fields. The grant allows for a maximum budget of $275,000 over two years, with a prohibition on clinical trials and a limit on new data generation to 20% of project costs. Interested applicants should note that proposals are due by January 7, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Exploratory/Developmental Research Grant to develop novel theories and methodologies for understanding the genetic architecture of complex human traits. The objective is to support innovative research that explores both genetic and non-genetic factors influencing trait variation across biological, social, and ecological levels, with a particular emphasis on addressing cancer disparities and employing systems epidemiology modeling. This grant allows for a budget of up to $275,000 over a two-year period, and applications are open to a diverse range of organizations, including higher education institutions and nonprofits. Interested applicants can find more information and submit their proposals by the close date of January 7, 2027, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U01 Clinical Trial Not Allowed)" aimed at enhancing the understanding of psychiatric disorders in diverse populations, particularly those of African ancestry. This initiative seeks applications for cooperative agreements that will focus on accelerating gene discovery efforts and promoting global mental health equity, addressing the existing gap in genomic studies that predominantly center on European populations. The funding is intended to support innovative research approaches that incorporate community engagement and career development for underrepresented groups, with a project period of up to five years. Interested applicants can find more details and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with the application deadline set for February 13, 2026.
    Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at enhancing the use and sharing of genomic information in clinical care across diverse populations. This initiative seeks proposals that focus on understanding the implementation of genomic medicine, addressing barriers to access, and developing analytical tools for clinical genomic data, with a strong emphasis on inclusivity for populations experiencing health disparities. The NIH has allocated approximately $2.4 million for three projects, with an additional project funded by the National Cancer Institute, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties must submit their applications by February 11, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders" (PAR-25-327), aimed at supporting Investigational New Drug (IND)-enabling studies and preparations for First-in-Human (FIH) clinical trials. This initiative focuses on advancing innovative gene-based therapies, such as oligonucleotides and viral vector approaches, for ultra-rare disorders affecting fewer than 6,000 patients, with an emphasis on projects that demonstrate robust proof of concept data and readiness for clinical trials. Eligible applicants include a wide range of organizations, including higher education institutions and various nonprofit and for-profit entities, with applications requiring detailed project planning and compliance with Good Manufacturing Practices (GMP). The application period opens on January 9, 2025, with a close date of October 8, 2027, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the R21 Clinical Trial Not Allowed grant, aimed at advancing research into the cellular and molecular biology of complex brain disorders. This funding opportunity encourages innovative research focused on high-confidence risk factors associated with conditions such as schizophrenia, major depression, and anxiety, emphasizing hypothesis-generating studies rather than disorder modeling. The grant supports projects with budgets up to $275,000 over a two-year period, with applications due starting January 16, 2025, and a closing date of September 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-25-037.html.
    Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics and data science. This initiative encourages applications that focus on developing novel analytical methodologies, tools, and software that can be broadly applied to enhance human health and disease understanding, with an emphasis on scalable systems for managing complex genomic data. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal colleges, with a maximum budget of $500,000 per year available for projects lasting up to five years. The application submission period opens on January 6, 2025, and closes on September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovation in the application of genomic information in clinical care, particularly for populations experiencing health disparities. The initiative seeks to enhance understanding of how to effectively implement and share genomic technologies across diverse communities, including racial and ethnic minorities, underserved rural populations, and sexual and gender minority groups. With an expected total funding of approximately $1.5 million for fiscal year 2024, individual project budgets may reach up to $250,000. Interested applicants must submit their proposals by February 11, 2025, and can find additional details and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.